14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 2696.HK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Shanghai Henlius Biotech Inc stock upgraded from Buy Candidate to Strong Buy Candidate after Wednesday trading session.
(Updated on Apr 24, 2024)

Buy or Hold candidate since Apr 02, 2024 Gain 9.79% PDF

The Shanghai Henlius Biotech Inc stock price gained 2.88% on the last trading day (Wednesday, 24th Apr 2024), rising from HK$15.26 to HK$15.70. During the last trading day the stock fluctuated 4.90% from a day low at HK$15.10 to a day high of HK$15.84. The price has risen in 5 of the last 10 days and is up by 5.37% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 164 thousand more shares were traded than the day before. In total, 584 thousand shares were bought and sold for approximately HK$9.16 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.74% during the next 3 months and, with a 90% probability hold a price between HK$15.98 and HK$18.96 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

2696.HK Signals & Forecast

Mostly positive signals in the chart today. The Shanghai Henlius Biotech Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at HK$14.97 and HK$14.51. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, February 19, 2024, and so far it has risen 23.04%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Shanghai Henlius Biotech Inc stock

Shanghai Henlius Biotech Inc finds support from accumulated volume at HK$15.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved HK$0.740 between high and low, or 4.90%. For the last week, the stock has had daily average volatility of 4.81%.

Our recommended stop-loss: HK$15.16 (-3.44%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 78 and this increases the risk substantially. There is a buy signal from a pivot bottom found 44 days ago.)

Trading Expectations (2696.HK) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Shanghai Henlius Biotech Inc to open at HK$15.55, and during the day (based on 14 day Average True Range), to move between HK$15.08 and HK$16.32, which gives a possible trading interval of +/-HK$0.620 (+/-3.95%) up or down from last closing price. If Shanghai Henlius Biotech Inc takes out the full calculated possible swing range there will be an estimated 7.90% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ HK$15.26, some HK$0.440 (2.80%) from the current price of HK$15.70, our system finds the risk reward attractive.

Is Shanghai Henlius Biotech Inc stock A Buy?

Shanghai Henlius Biotech Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 7.913 Strong Buy Candidate Upgraded

Predicted Opening Price for Shanghai Henlius Biotech Inc of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
HK$15.55 ( 0.98%) HK$15.70

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 2696.HK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.29 3.74 %
R2 16.00 1.94 %
R1 15.83 0.82 %
Current price: 15.70
Support S1 15.26 -2.78 %
S2 15.09 -3.89 %
S3 14.81 -5.69 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 15.70
Support S1 15.26 -2.80%
S2 15.10 -3.82%
S3 14.54 -7.39%

FAQ

What is the symbol for Shanghai Henlius Biotech Inc Stock and on which exchange is it traded?
The symbol for Shanghai Henlius Biotech Inc is 2696.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell Shanghai Henlius Biotech Inc Stock?
Shanghai Henlius Biotech Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Shanghai Henlius Biotech Inc Stock?
Shanghai Henlius Biotech Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Shanghai Henlius Biotech Inc Stock.

What's the current price of Shanghai Henlius Biotech Inc Stock?
As of the end of day on the Apr 24, 2024, the price of an Shanghai Henlius Biotech Inc (2696.HK) share was HK$15.70.

What is the 52-week high and low for Shanghai Henlius Biotech Inc Stock?
The 52-week high for Shanghai Henlius Biotech Inc Stock is HK$16.44 and the 52-week low is HK$9.60.

What is the market capitalization of Shanghai Henlius Biotech Inc Stock?
As of the Apr 24, 2024, the market capitalization of Shanghai Henlius Biotech Inc is 8.315B.
Click to get the best stock tips daily for free!

About Shanghai Henlius Biotech Inc

Shanghai Henlius Biotech Shanghai Henlius Biotech, Inc., a biopharmaceutical company, engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases. It offers HANLIKANG, a rituximab injection for treating non-hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis; HANQUYOU, a trastuzumab injection to treat breast and metastatic gastric cancer; HANDAYUAN, an adalimumab injection for t... 2696.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT